Equity Capital And Reserves Veränderung Datum
AbbVie USD 12.09B 772M 2023-09
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Astellas Pharma JPY 1.64T 60.93B 2023-09
AstraZeneca USD 37.2B 195M 2023-09
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Esperion Therapeutics USD -410004000 38.03M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
J&J USD 71.23B 3.92B 2023-09
Kyowa Hakko Kirin JPY 812.14B 17.36B 2023-09
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Opthea USD -5853180 62.32M 2023-06
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Regeneron Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.